by Urška Mrgole | Sep 15, 2026 | News
The Challenge Based Innovation 2026 programme began online on 1 September. Through introductory lectures, participating students are learning about particle accelerators and exploring how these technologies could benefit society. From online learning to Sarajevo The...
by Urška Mrgole | Sep 7, 2026 | News
Demand for Lu-177-based cancer therapies is expected to grow significantly across Europe and the wider region by 2040, according to recent analytical work carried out within the IFIGENEIA project, covering Cyprus, Slovenia, Greece, Croatia and North Macedonia. The...
by Urška Mrgole | Sep 3, 2026 | News
The European project IFIGENEIA is developing technologies and expertise for accelerator-based applications in nuclear medicine. As part of the project’s knowledge-transfer and capacity-building activities, accelerator-based techniques are also being explored for...
by Urška Mrgole | Aug 28, 2026 | Did you know - medicine, News
The story of iodine-131 began in the late 1930s, when physicists at MIT – including Saul Hertz and Arthur Roberts – first proposed that radioactive iodine could be used to treat thyroid disease. Their insight was elegant: the thyroid gland naturally...
by Urška Mrgole | Aug 10, 2026 | News, Video, Why IFIGENEIA matters
What does IFIGENEIA mean to YFOS? In this one-minute video, Theano Lampoudi shares what motivated YFOS to join the project and how IFIGENEIA supports the company’s vision for innovation and technological advancement. Watch the video to hear their...
